Island Pharmaceuticals Issues New Shares on Australian Securities Exchange
Island Pharmaceuticals Ltd has announced the issuance of 50,000 fully paid ordinary shares on the Australian Securities Exchange (ASX) under the security code ILA, effective January 22, 2025. This issuance is expected to bolster the company’s equity base, potentially enhancing its financial capacity to support ongoing research and development initiatives.
Island Pharmaceuticals Issues New Shares on Australian Securities Exchange